More scientists are gravitating toward studying rare diseases, potentially accelerating treatments for diseases that collectively affect about 25 million Americans, the National Institutes of Health (NIH) chief said.
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
AAPS Magazine helps pharmauceutical scientists excel in their jobs by providing current science, news, career advice, member recognition, AAPS offerings, and other valuable contemporary information.
2107 Wilson Blvd #700
Arlington, VA 22201
AAPS Customer Service